Flow cytometry and cell sorting are inetegral and non-dispensible components of modern biomedical research. These techniques allow for the rapid identification of individual cells within a mixed population based on such properties as cell surface antigen expression, cell cycle status, cell signaling, or fluorescencetagged transgenes. Furthermore, once cell populations are identified they can be isolated into discreet populuations via cell sorting. The University of Colorado Cancer Center Flow Cytometry Core is a state-ofthe- art facility that provides two machines capable of high speed cell sorting based on 7-color or 9-color parameters, respectively. Additionally the core provides three flow analysis machines capable of 4, 5, and 9- color analysis, respectively.The Flow Core also provides the Luminex system for multiplexed bead array analysis. Additionally Flow Core personnel provide a consulting service for analysis and cell sorting strategies. The Flow Core will be used extensively for investigators involved in skin disease: we will be capable of identifying and isolating various skin cell subpopulations, such as keratinocytes and keratinocyte stem cell populations, as well as isolating normal and tumor skin stem cells from tissues or cell cultures for further in vitro and in vivo analysis. Additionally investigators will be able to identify, isolate, and further assess phenotype-specific T cell or other immune cell populations associated with various skin pathologies. ore center support for the Flow Core will insure that investigators of the Skin Disease Research Core Center (SDRC) will have full access to all services provided by the Flow Cytometry and Cell Sorting Core at a discounted rate.
The services of this core component will allow SDRC investigators access to flow analysis of cells in skin disease models, both in vitro and in vivo. Moreover the Flow Cytometry Core will provide the only practical means of isolating rare stem cell populations or immune cell subsets from skin cell preparations or cell cultures. Funding of the Flow Cytometry Core will provide full access to core services at a discounted rate.
|Ishitsuka, Yosuke; Huebner, Aaron J; Rice, Robert H et al. (2016) Lce1 Family Members Are Nrf2-Target Genes that Are Induced to Compensate forÂ the Loss of Loricrin. J Invest Dermatol 136:1656-63|
|Liu, Ying; Snedecor, Elizabeth R; Zhang, Xu et al. (2016) Correction of Hair Shaft Defects through Allele-Specific Silencing of Mutant Krt75. J Invest Dermatol 136:45-51|
|Reynolds, Susan D; Rios, Cydney; Wesolowska-Andersen, Agata et al. (2016) Airway Progenitor Clone Formation Is Enhanced by Y-27632-Dependent Changes in the Transcriptome. Am J Respir Cell Mol Biol 55:323-36|
|Mukherjee, Nabanita; Lu, Yan; Almeida, Adam et al. (2016) Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells. Oncotarget :|
|Tilley, Cynthia; Deep, Gagan; Agarwal, Chapla et al. (2016) Silibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation. Mol Carcinog 55:3-14|
|Zhang, Lei; Ferreyros, Michael; Feng, Weiguo et al. (2016) Defects in Stratum Corneum Desquamation Are the Predominant Effect of Impaired ABCA12 Function in a Novel Mouse Model of Harlequin Ichthyosis. PLoS One 11:e0161465|
|Kohler, Stephanie L; Pham, Michael N; Folkvord, Joy M et al. (2016) Germinal Center T Follicular Helper Cells Are Highly Permissive to HIV-1 and Alter Their Phenotype during Virus Replication. J Immunol 196:2711-22|
|Jin, Ying; Andersen, Genevieve; Yorgov, Daniel et al. (2016) Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. Nat Genet 48:1418-1424|
|Du, L; Chen, X; Cao, Y et al. (2016) Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFÎ² signaling. Oncogene 35:4641-52|
|Morton, J J; Bird, G; Keysar, S B et al. (2016) XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer. Oncogene 35:290-300|
Showing the most recent 10 out of 48 publications